JF

Jason Fuller

Partner at Deerfield Management

New York, New York

VC
Investor

Invests in

Stages:

Series A

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Venture Capital
Medical Devices
Drug Delivery
Engineering
Immunology
Biotechnology
Lifesciences
Technology Transfer
Commercialization
Start-ups
R&D
Science
Laboratory
Private Equity
Entrepreneurship
Biopharmaceuticals
Drug Discovery
Validation
Due Diligence
Pharmaceutical Industry

Education

Lists including Jason

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Actio Biosciences

Series A

Total Funding: $55M

Jounce Therapeutics

Series A

Total Funding: $47M

Work Experience

DM
Deerfield Management

2021

  • Partner

    2021

NE
New Enterprise Associates (NEA)

2014 - 2021

  • Principal

    2014 - 2021

JT
Jounce Therapeutics, Inc.

2013 - 2014

  • Director Corporate Development

    2013 - 2014

TR
Third Rock Ventures

2008 - 2013

  • Principal

    2010 - 2013

  • Senior Associate

    2008 - 2010

M
MIT

2001 - 2008

  • MIT Langer Lab, Doctorial Research

    2001 - 2008

    PhD research in Chemical Engineering. Thesis focused on delivery of nucleic acids targeting the immune system..

M$
MIT $100K Entrepreneurship Competition

2005 - 2006

  • Co-President

    2005 - 2006

BH
Baxter Healthcare

2000 - 2000

  • Validation Engineer

    2000 - 2000

3
3M

1997 - 1999

  • Co-Op Student

    1997 - 1999